Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE(2)

PURPOSE: 83b1 is a novel quinoline derivative that has been shown to inhibit cancer growth in human esophageal squamous cell carcinoma (ESCC). This study was conducted to comprehensively evaluate the cytotoxic effects of 83b1 on a series of ESCC cell lines and investigate the mechanisms by which 83b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Res Treat
Autors principals: Pun, Ivan Ho Yuen, Chan, Dessy, Chan, Sau Hing, Chung, Po Yee, Zhou, Yuan Yuan, Law, Simon, Lam, Alfred King Yin, Chui, Chung Hin, Chan, Albert Sun Chi, Lam, Kim Hung, Tang, Johnny Cheuk On
Format: Artigo
Idioma:Inglês
Publicat: Korean Cancer Association 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266386/
https://ncbi.nlm.nih.gov/pubmed/27456944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.190
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars